http://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2021-204
B of A Securities Upgrades Alignment Healthcare to Buy, Lowers Price Target to $14
B of A Securities analyst Kevin Fischbeck upgrades Alignment Healthcare (NASDAQ:ALHC) from Neutral to Buy and lowers the price target from $18 to $14.